Outcomes of 1503 cycles of modified natural cycle in vitro fertilization: a single-institution experience
暂无分享,去创建一个
M. Velez | K. Buzaglo | S. Phillips | I. Kadoch | T. Shaulov
[1] Gemma Escribano,et al. Severe Ovarian Hyperstimulation Syndrome After Gonadotropin-Releasing Hormone (Gnrh) Agonist Trigger And ''Freeze-All'' Approach In Gnrh Antagonist Protocol , 2015 .
[2] R. Machtinger,et al. Is the modified natural in vitro fertilization cycle justified in patients with "genuine" poor response to controlled ovarian hyperstimulation? , 2014, Fertility and sterility.
[3] P. Devroey,et al. Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all" approach in GnRH antagonist protocol. , 2014, Fertility and sterility.
[4] M. Haadsma,et al. Effectiveness of indometacin to prevent ovulation in modified natural-cycle IVF: a randomized controlled trial. , 2013, Reproductive biomedicine online.
[5] B. Ata,et al. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG. , 2013, Human reproduction.
[6] M. Velez,et al. Rapid policy change to single-embryo transfer while maintaining pregnancy rates per initiated cycle. , 2013, Reproductive biomedicine online.
[7] M. Payson,et al. Utilization and success rates of unstimulated in vitro fertilization in the United States: an analysis of the Society for Assisted Reproductive Technology database. , 2010, Fertility and sterility.
[8] H. Tournaye,et al. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. , 2012, Human reproduction.
[9] A. Zini,et al. Surgically retrieved spermatozoa versus ejaculated spermatozoa in modified natural IVF-ICSI cycles. , 2012, Reproductive biomedicine online.
[10] D. Bodri,et al. Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre, Japanese cohort , 2012, Reproductive Biology and Endocrinology.
[11] D. Bodri,et al. Short-term, low-dose, non-steroidal anti-inflammatory drug application diminishes premature ovulation in natural-cycle IVF. , 2012, Reproductive biomedicine online.
[12] F. Bissonnette,et al. Modified natural-cycle in vitro fertilization should be considered as the first approach in young poor responders. , 2011, Fertility and sterility.
[13] L. Gianaroli,et al. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. , 2011, Human reproduction.
[14] M. Sbracia,et al. Natural-cycle in vitro fertilization in poor responder patients: a survey of 500 consecutive cycles. , 2009, Fertility and sterility.
[15] P. Humaidan. Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study. , 2009, Reproductive biomedicine online.
[16] O. Kato,et al. Natural IVF cycles may be desirable for women with repeated failures by stimulated IVF cycles , 2008, Journal of Assisted Reproduction and Genetics.
[17] B. Couturier,et al. Spontaneous ovulation rate before oocyte retrieval in modified natural cycle IVF with and without indomethacin. , 2008, Reproductive biomedicine online.
[18] S. Hamamah,et al. Le cycle naturel en fécondation in vitro chez les mauvaises répondeuses , 2007 .
[19] M. Pelinck,et al. Cumulative pregnancy rates after a maximum of nine cycles of modified natural cycle IVF and analysis of patient drop-out: a cohort study. , 2004, Human reproduction.
[20] B. Couturier,et al. Controlled natural cycle IVF: experience in a world of stimulation. , 2007, Reproductive biomedicine online.
[21] S. Hamamah,et al. [Natural cycle in vitro fertilization cycle in poor responders]. , 2007, Gynecologie, obstetrique & fertilite.
[22] M. Pelinck,et al. Cumulative pregnancy rates after three cycles of minimal stimulation IVF and results according to subfertility diagnosis: a multicentre cohort study. , 2006, Human reproduction.
[23] R. Fanchin,et al. In vitro fertilization and embryo transfer in seminatural cycles for patients with ovarian aging. , 2005, Fertility and sterility.
[24] M. Pelinck,et al. Minimal stimulation IVF with late follicular phase administration of the GnRH antagonist cetrorelix and concomitant substitution with recombinant FSH: a pilot study. , 2005, Human reproduction.
[25] N. Frydman,et al. La place du cycle semi-naturel dans la prise en charge de patientes ayant un mauvais pronostic en fécondation in vitro , 2004 .
[26] C. Aragona,et al. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. , 2004, Fertility and sterility.
[27] N. Frydman,et al. [The role of the semi natural cycle as option of treatment of patients with a poor prognosis for successful in vitro fertilization]. , 2004, Journal de gynecologie, obstetrique et biologie de la reproduction.
[28] M. Pelinck,et al. Efficacy of natural cycle IVF: a review of the literature. , 2002, Human reproduction update.
[29] R. Storeng,et al. Natural cycle IVF in unexplained, endometriosis-associated and tubal factor infertility. , 2001, Human reproduction.
[30] J. Donnez,et al. Outcome of in-vitro fertilization through natural cycles in poor responders. , 1999, Human reproduction.
[31] R. Fanchin,et al. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation. , 1999, Human reproduction.
[32] H. Burger,et al. Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition. , 1991, The Journal of clinical endocrinology and metabolism.